« Back to Record
Ogbogu, P. U., Roufosse, F., Akuthota, P., Kuna, P., Groh, M., Reiter, A., Yokota, A., Siddiqui, S., Mutsaers, P. P., Li, B., Khoury, P., Bahadori, L. L., Bednarczyk, A., Bouma, G., Brooks, L., Ferreira, J., Grindebacke, H., Ho, C. C., Jain, P., Palmer, R. R., Jison, M., & Klion, A. (2026). Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial. Nature medicine, 32(6), 2319. doi:10.1038/s41591-026-04315-8
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/409000



